The pharmaceutical, technology sectors have delivered exceptional returns for investors in 2025, with several established dividend-paying stocks outperforming the broader market. This analysis highlights three standout performers – AbbVie Inc., Amgen Inc., and International Business Machines Corporation (IBM) – all exceeding a year-to-date gain of 30%. These blue-chip companies not only offer growth potential but also provide steady dividend income, appealing to investors seeking both growth and regular payouts. As of November 26, 2025, each has demonstrated resilience in a challenging market environment while maintaining or increasing their dividend commitments.